- Home
- AMST vs EVAX Comparison
AMST vs EVAX Comparison
Compare AMST & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- EVAX
- Stock Information
- Founded
- AMST 2017
- EVAX 2008
- Country
- AMST United States
- EVAX Denmark
- Employees
- AMST N/A
- EVAX N/A
- Industry
- AMST Computer Software: Prepackaged Software
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMST Technology
- EVAX Health Care
- Exchange
- AMST Nasdaq
- EVAX Nasdaq
- Market Cap
- AMST 7.4M
- EVAX 8.7M
- IPO Year
- AMST 2020
- EVAX 2021
- Fundamental
- Price
- AMST $4.41
- EVAX $0.92
- Analyst Decision
- AMST
- EVAX Strong Buy
- Analyst Count
- AMST 0
- EVAX 2
- Target Price
- AMST N/A
- EVAX $11.00
- AVG Volume (30 Days)
- AMST 47.6K
- EVAX 971.7K
- Earning Date
- AMST 02-12-2025
- EVAX 10-31-2024
- Dividend Yield
- AMST N/A
- EVAX N/A
- EPS Growth
- AMST N/A
- EVAX N/A
- EPS
- AMST N/A
- EVAX N/A
- Revenue
- AMST $114,798.00
- EVAX $3,295,000.00
- Revenue This Year
- AMST N/A
- EVAX $4,845.21
- Revenue Next Year
- AMST N/A
- EVAX $30.30
- P/E Ratio
- AMST N/A
- EVAX N/A
- Revenue Growth
- AMST N/A
- EVAX N/A
- 52 Week Low
- AMST $1.85
- EVAX $0.83
- 52 Week High
- AMST $6.27
- EVAX $13.61
- Technical
- Relative Strength Index (RSI)
- AMST 57.94
- EVAX 35.28
- Support Level
- AMST $4.19
- EVAX $0.83
- Resistance Level
- AMST $5.18
- EVAX $1.22
- Average True Range (ATR)
- AMST 0.53
- EVAX 0.14
- MACD
- AMST -0.01
- EVAX 0.03
- Stochastic Oscillator
- AMST 25.69
- EVAX 20.04
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.